शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BSEARCHIT ORGANOSYS LTD.· Chemicals & PetrochemicalsHighNeutral
Announced Thu, 3 Sept, 2026 · 18:26 IST

Board hikes authorised capital, approves share swap to acquire Archit Life Science

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-1.5%Reaction day
₹65.70
prior close
₹65.20
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.7%-2.2% vs market
Commodity Chemicals peers, median of 59sector+0.1%-1.6% vs sector

On the reaction day the stock moved 2.2 pts less than Nifty Microcap 250 and 1.6 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.0
10m
+0.0
15m
+0.0
30m
+0.0
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-1.5+0.7-2.2+0.1-1.6
Next day
-1.3+1.1-2.4+1.2-2.5
2d
+0.4+1.6-1.2+0.6-0.2
3d
+2.0+1.5+0.5+1.3+0.7
4d
-1.1+1.3-2.3-0.4-0.6
5d
+3.3+1.4+2.0-0.2+3.6
1w
+0.6-2.1+2.7-1.9+2.6
15d
-5.5-0.9-4.6-0.8-4.6
1m
-4.9-1.4-3.4-2.8-2.1
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Commodity Chemicals peers, median of 59Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board raised authorised share capital from Rs 25 Cr to Rs 60 Cr and approved issuing up to 3.72 Cr equity shares at Rs 65 each (Rs 55 premium on Rs 10 face value) through a preferential share swap. The shares will be exchanged to acquire 1.86 Cr shares (92.20%) of Archit Life Science Limited, valued at Rs 130 per share. Allottees include promoter family members and non-promoter investors. Needs shareholder and regulatory approval.

Likely market impact

Share swap will dilute existing shareholders but adds Archit Life Science as a subsidiary. Pending shareholder and other approvals.